Related Experiment Videos
Propofol pharmacokinetics in a dwarfism patient
T Tsubokawa1, K Yamamoto, A Komuro
1Department of Anesthesiology and Intensive Care Medicine, School of Medicine, Faculty of Medicine, Kanazawa University, Kanazawa, Japan. tsune@anesth.m.kanazawa-u.ac.jp
Acta Anaesthesiologica Scandinavica
|April 16, 2003
Summary
Pharmacokinetic data for propofol in dwarfism patients is scarce. This study investigated propofol pharmacokinetics during surgery in a dwarfism patient, finding differences between supine and prone positions.
Area of Science:
- Anesthesiology
- Pharmacology
- Clinical Pharmacy
Background:
- Accurate anesthetic depth control relies on pharmacokinetic data.
- Limited propofol pharmacokinetic data exists for patients with dwarfism.
- This study addresses this gap by investigating propofol pharmacokinetics in a dwarfism patient.
Observation:
- A 40-year-old male dwarfism patient underwent a two-stage spinal decompression (anterior supine, posterior prone).
- Arterial blood samples were collected for pharmacokinetic analysis during anesthesia.
- Propofol pharmacokinetics were assessed in both supine and prone positions.
Findings:
- Steady-state volume of distribution and clearance were 180 L and 0.92 L/min in the supine position, respectively.
- These values decreased to 127 L and 0.74 L/min in the prone position, despite dopamine infusion.
- Supine position data aligned with established Gepts' parameters, suggesting Target-Controlled Infusion (TCI) feasibility.
Implications:
- Target-Controlled Infusion (TCI) of propofol may be viable in the supine position for dwarfism patients.
- Anesthesia management requires careful dose adjustment to prevent overdosing in the prone position.
- Further research is needed to validate these findings in a larger dwarfism patient cohort.